Opko Increased Testing Revenues Boost Opko Health Q2 Revenues 47 Percent The firm saw increases in SARS-CoV-2, clinical, and genomic testing and processed approximately 2.8 million COVID-19 PCR tests. Opko Health Q1 Revenues More Than Double Due to COVID-19 Test Demand The company reported revenues of $545.2 million compared to $211.5 million in the year-ago quarter, primarily driven by COVID-19 testing. BioReference Labs Inks Deal to Provide Rapid PCR, Point-of-Care COVID-19 Testing for MLB The firm is using Mesa Biotech's Accula system for the testing, beginning Thursday, the start of the 2021 MLB season. Opko Health Q4 Revenues More Than Double Thanks to COVID-19 Testing The company's service revenues increased 157 percent to $457.9 million due to significant COVID-19 testing volumes, slightly offset by lower base business volumes. Opko Health Q3 Revenues Up 87 Percent The firm's subsidiary BioReference Laboratories performed 3.5 million COVID-19 PCR tests and 300,000 serology tests during the quarter. Aug 27, 2020 As Abbott Stock Rises on EUA for Antigen Test, Competitors' Shares Take a Hit Aug 12, 2020 GeneDx Inks Neonatal Genomic Services Deal With Pediatrix Medical Group Mar 14, 2020 Trump Administration Highlights Role of Private Sector in Effort to Increase Coronavirus Testing Mar 5, 2020 Commercial Labs Step up Coronavirus Test Efforts After FDA Guidance Jan 16, 2020 JP Morgan Healthcare Day 3: Exact Sciences, NanoString, Natera, Horizon, Accelerate Dx, GenMark, More Dec 6, 2019 Local Coverage Determinations Roundup: Transplant Genomics, Opko Health Jan 12, 2018 GeneDx, Radboud UMC Collaborate on Research Into Neurodevelopmental Disorders Nov 22, 2017 Longstanding Genetic Testing Website GeneTests Closing Sep 19, 2017 BioReference, The Garage Form Alliance to Advance Patient Care Jun 7, 2017 UC Health to Have Expanded Access to GeneDx Tests Mar 10, 2017 Opko Hopes Medicare Decision Will Help Drive Adoption of 4Kscore Prostate Cancer Dx Premium Nov 7, 2016 Opko Q3 Revenues Up 108 Percent on Strength of BioReference Sales Oct 10, 2016 GeneDx Launches Prenatal Exome Sequencing Test, Plans to Expand Into New Dx Areas Premium Oct 7, 2016 MDx Experts See Need for More Test Integration in Providing Comprehensive Cancer Diagnoses Premium May 9, 2016 Opko Q1 Revenues Up Nearly Ninefold Nov 10, 2015 Opko Posts Big Q3 Revenue Gain on Acquisitions Aug 20, 2015 Opko Completes $1.47B Buy of Bio-Reference Aug 19, 2015 Opko Signs Contract With Three Insurers Jul 2, 2015 Opko's Acquisition of Bio-Reference Labs Passes US Antitrust Review Jun 8, 2015 Bio-Reference Q2 Revenues Grow 11 Percent Load More Breaking News UK Biobank Study Investigates Incomplete Penetrance of Mendelian Disease Variants MDxHealth Q3 Revenues Grow 23 Percent BioMérieux Q3 Revenues Increase 11 Percent, Firm Raises 2021 Guidance Germline Cancer Risk Genes May Hold Rhabdomyosarcoma Survival Clues, Study Suggests Danaher Q3 Revenues Rise 23 Percent, Beat Wall Street Estimates Horse Genetics Study Reveals Origins of Domestication, Use in Human Culture The Scan Guidelines for Ancient DNA Work More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature. And Cleared A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times. Suit Over Allegations The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director. Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.